Found: 8
Select item for more details and to access through your institution.
Efficacy and safety of ruxolitinib in steroid-refractory graftversus-host disease: A meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.954268
- By:
- Publication type:
- Article
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.757002
- By:
- Publication type:
- Article
A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.862526
- By:
- Publication type:
- Article
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00278-x
- By:
- Publication type:
- Article
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.773394
- By:
- Publication type:
- Article
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft- versus -host disease after haploidentical allogeneic hematopoietic stem cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207211072838
- By:
- Publication type:
- Article
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 907, doi. 10.1007/s00277-023-05118-4
- By:
- Publication type:
- Article
Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft- Versus -Host Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.749266
- By:
- Publication type:
- Article